%0 Journal Article
%T Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer
%A Christopher Sinesi
%A Gary L. Larson
%A John Han-Chih Chang
%A Joshua R. Niska
%A Lucius Doh
%A Mark Pankuch
%A Matthew Q. Schmidt
%A Rossio Rodriquez
%A Sameer R. Keole
%A William F. Hartsell
%J Archive of "Advances in Radiation Oncology".
%D 2018
%R 10.1016/j.adro.2018.02.004
%X Randomized evidence for extreme hypofractionation in prostate cancer is lacking. We aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and extreme hypofractionated radiation in a phase 3 randomized trial
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128091/